Balthazar da Silveira Carlos A, Rasador Ana C D, Vidotto Laura, Nogueira Raquel, Scott Melvin W, Camacho Diego, Lima Diego L
Dignity Health St. Joseph's Hospital, Phoenix, AZ, USA.
Anhembi Morumbi University, Sao Paulo, Brazil.
Surg Endosc. 2025 Sep 16. doi: 10.1007/s00464-025-12207-0.
Obesity has become a global comorbidity with increasing prevalence over the last decade. It is associated with an elevated risk for the development of ventral hernias. Bariatric surgery aims to address obesity through surgical intervention, which has become increasingly safe over time. However, a comparative meta-analysis with a double-arm evaluation of concomitant ventral hernia repair (VHR) and weight loss surgery is not yet available in the literature. Hence, we performed a systematic review and meta-analysis of simultaneous VHR and bariatric surgery.
Cochrane, Embase, Scopus, Scielo, and PubMed were systematically searched for studies comparing concomitant bariatric surgery and VHR with bariatric surgery alone or staged repair. Outcomes assessed for comparative meta-analysis were surgical site infection (SSI), dehiscence, readmission and reoperation, deep venous thrombosis (DVT) and pulmonary embolism (PE), overall mortality, operative time, and length of hospital stay (LOS). SSI was also analyzed separately as a superficial or deep infection. We also performed a single-arm meta-analysis of incarceration within the staged repair groups with a bariatric surgery as the first procedure and a single-arm meta-analysis of recurrence following concomitant bariatric surgery and VHR. Statistical analysis was performed with R Studio.
805 studies were screened and 26 were thoroughly reviewed. Six studies were included, comprising a total of 131,323 patients, of whom 3002 (2.3%) underwent simultaneous bariatric and VHR procedures. Simultaneous repair was associated with an increase of 39.4 min (95% CI 26.17 to 52.63; p < 0.01) in the operative time. We found an increased readmission rate for the concomitant procedures (OR 1.48; 95% CI 1.1 to 1.99; p < 0.01), but no differences were found in reoperation rates (OR 2.97; 95% CI 1.0 to 8.84; p = 0.05). Concomitant procedures were also associated with higher DVT (OR 2.54; 95% CI 1.36 to 4.72; p < 0.01) and PE rates compared to separated procedures (OR 3.08; 95% CI 1.57 to 6.05; p < 0.01). No differences were found in overall SSI (OR 1.1; 95% CI 0.59 to 2.12; p = 0.74) and superficial (OR 0.94; 95% CI 0.48 to 1.84; p = 0.86) or deep (OR 7.02; 95% CI 0.36 to 136.1; p = 0.2) SSI. No statistically significant differences were found in dehiscence rates between the groups (OR 0.2; 95% CI 0.01 to 4.16; p = 0.3). Concomitant procedures were associated with an increase of 0.35 days in LOS (95% CI 0.1 to 0.59; p = 0.004) and with increased mortality odds (OR 3.99; 95% CI 1.92 to 8.3; p < 0.01). The proportional meta-analysis found an incarceration rate of 22.95 (95% CI 10.9 to 42) for the patients who delayed the VHR and a recurrence rate of 7.61 per 100 patients (95% CI 1.6 to 29.6) for the patients who underwent concomitant surgery.
Our systematic review and meta-analysis found an increase in DVT, PE, readmission, operative time, LOS, and mortality for concomitant procedures. Incarceration rates of 22.95 were found for delayed VHR. Further research is needed to analyze individual bariatric surgery and VHR techniques and draw a more precise conclusion on this subject.
肥胖已成为一种全球共病,在过去十年中患病率不断上升。它与腹疝发生风险升高相关。减重手术旨在通过手术干预解决肥胖问题,随着时间推移,该手术已变得越来越安全。然而,文献中尚无对同期腹疝修补术(VHR)和减重手术进行双臂评估的比较性荟萃分析。因此,我们对同期VHR和减重手术进行了系统评价和荟萃分析。
系统检索Cochrane、Embase、Scopus、Scielo和PubMed,查找比较同期减重手术和VHR与单纯减重手术或分期修补术的研究。用于比较性荟萃分析的评估结局包括手术部位感染(SSI)、切口裂开、再入院和再次手术、深静脉血栓形成(DVT)和肺栓塞(PE)、总死亡率、手术时间和住院时间(LOS)。SSI也分别作为浅表或深部感染进行分析。我们还对以减重手术作为首个手术的分期修补组内的嵌顿进行了单臂荟萃分析,以及对同期减重手术和VHR后的复发进行了单臂荟萃分析。使用R Studio进行统计分析。
筛选了805项研究,对26项进行了全面审查。纳入6项研究,共131323例患者,其中3002例(2.3%)接受了同期减重和VHR手术。同期修补与手术时间增加39.4分钟相关(95%CI 26.17至52.63;p<0.01)。我们发现同期手术的再入院率增加(OR 1.48;95%CI 1.1至1.99;p<0.01),但再次手术率无差异(OR 2.97;95%CI 1.0至8.84;p = 0.05)。与分开手术相比,同期手术的DVT(OR 2.54;95%CI 1.36至4.72;p<0.01)和PE发生率也更高(OR 3.08;95%CI 1.57至6.05;p<0.01)。总体SSI(OR 1.1;95%CI 0.59至2.12;p = 0.74)以及浅表(OR 0.94;95%CI 0.48至1.84;p = 0.86)或深部(OR 7.02;95%CI 0.36至136.1;p = 0.2)SSI均无差异。两组间切口裂开率无统计学显著差异(OR 0.2;95%CI 0.01至4.16;p = 0.3)。同期手术与LOS增加0.35天相关(95%CI 0.1至0.59;p = 0.004),且与死亡几率增加相关(OR 3.99;95%CI 1.92至8.3;p<0.01)。比例荟萃分析发现,延迟VHR的患者嵌顿率为22.95(95%CI 10.9至42),接受同期手术的患者复发率为每100例患者7.61(95%CI 1.6至29.6)。
我们的系统评价和荟萃分析发现,同期手术的DVT、PE、再入院、手术时间、LOS和死亡率增加。延迟VHR的嵌顿率为22.95。需要进一步研究分析个体减重手术和VHR技术,以便就该主题得出更精确的结论。